


A thorough venous leg ulcer assessment (ABI, CEAP classification, periwound findings) determines whether your treatment plan succeeds and whether your claim gets paid. Skip a step, and you risk failed grafts, wrong diagnoses, and denied reimbursement. This guide connects assessment components to the documentation language and billing codes payers expect.
A provider applied a skin substitute to what looked like a venous ulcer, but the Ankle-Brachial Index (ABI) was 0.6. The graft failed. The claim was denied. The patient needed a vascular consult that should’ve happened weeks earlier (composite case).
That outcome starts with an incomplete assessment. A missed ABI. A CEAP stage absent from the note. Periwound findings in language payers don't recognize.
Every finding you document during a venous leg ulcer assessment points toward a specific treatment pathway and a specific billing outcome.
When these pieces connect, your treatment plan is defensible. When they don't, you risk exposure on both fronts.
Contact our team to see how we can support your workflow.
Complete all five steps before selecting a product or submitting a claim. Each feeds directly into your documentation and billing.
Note location, wound bed, margins, and exudate. Be specific: "3.2 x 2.1 cm ulcer, left medial malleolus, irregular margins, moderate serous exudate, granulation tissue at base." Never write "wound noted on left leg."
Record the numeric ABI value. This determines compression safety and flags arterial involvement. "Pulses present" isn't enough.
Assign and document the CEAP stage. This drives ICD-10 code selection and establishes medical necessity.
Document hemosiderin staining, edema type and severity, lipodermatosclerosis, and venous eczema. Use exact clinical terms. "Skin changes noted" won't cut it.
Document why your intervention matches the clinical picture. Include ABI value, CEAP stage, and periwound findings. This is what payers review during authorization.
The ABI separates venous from mixed or arterial etiology. A wound may appear venous, but the ABI indicates otherwise. That's why the vascular assessment isn't optional.
At the Bedside, Look for These Patterns
Documenting Etiology for Payers
Don't write "leg ulcer" or "chronic wound." Specify the etiology, location, ABI value, and CEAP stage.
Example: "Venous stasis ulcer of left lower extremity, medial malleolus, ABI 1.1, CEAP C6."
For Mixed Etiology, Document Both Components
"Lower extremity ulcer with venous and arterial components. ABI = 0.7 indicating moderate arterial disease. Vascular referral placed [date]. Compression held pending vascular clearance."
This language shows clinical reasoning and protects you during an audit.
The ABI is the single most important objective test in your assessment. It confirms arterial involvement and determines compression safety. This ABI technique video walks through proper measurement.
|
ABI Value |
Interpretation |
Clinical Action |
|
> 1.4 |
Vessel calcification (falsely elevated) |
Refer to vascular specialist; consider toe pressures or TcPO₂ for accurate assessment |
|
1.0–1.4 |
Normal |
Safe to apply full compression therapy; proceed with venous treatment plan |
|
0.9–1.0 |
Acceptable |
Safe to apply full compression therapy; proceed with venous treatment plan |
|
0.8–0.9 |
Some arterial disease |
Treat cardiovascular risk factors; full compression may be appropriate with close monitoring |
|
0.5–0.8 |
Moderate arterial disease |
Vascular consult needed before treatment; modified compression only (inelastic wraps, reduced layers) |
|
< 0.5 |
Severe arterial disease |
Compression contraindicated; urgent vascular referral; do not apply skin substitutes until cleared |
Source: Stanford Medicine 25 — Ankle-Brachial Index
Knowing the number isn't enough, document what you did with it. An ABI of 0.7 with no documented vascular referral is a red flag for auditors.
RenewMed Tip: Write "ankle-brachial index = 1.1" in your notes, not "pulses present" or "adequate circulation." Payers look for the actual value.
H2: CEAP Classification: Mapping Clinical Findings to ICD-10 Codes
The CEAP system classifies chronic venous disease from C0 (no visible signs) through C6 (active ulcer). The stage you document determines which ICD-10 codes are defensible on your claim.
CEAP stands for:
The American Venous Forum created an extensive guide on how to use the classification system. However, in this case we’re focusing on the C.
|
CEAP Stage |
ICD-10 Code |
Documentation Language (Payer-Preferred) |
|
C4a (pigmentation, eczema) |
I83.0xx (varicose veins with ulcer) |
"CEAP C4a: venous eczema and hemosiderin staining present, consistent with chronic venous insufficiency" |
|
C4b (lipodermatosclerosis, atrophie blanche) |
I83.0xx (varicose veins with ulcer) |
"CEAP C4b: lipodermatosclerosis and subcutaneous fibrosis documented, indicating advanced venous disease" |
|
C5 (healed ulcer) |
I87.2 (venous insufficiency) + Z87.39 |
"CEAP C5: healed venous ulcer with underlying chronic venous insufficiency (I87.2); history of ulceration (Z87.39)" |
|
C6 (active ulcer) |
I87.2 + L97.xxx (site, laterality, depth) |
"CEAP C6: active venous stasis ulcer, [location], [size], with chronic venous insufficiency; L97.[xxx] reflecting [depth]" |
Example: A venous ulcer on the right medial ankle extending to fat = I87.2 + L97.314.
The L97.xxx seventh character is critical. Document whether the wound is limited to skin breakdown, extends to fat, reaches muscle, or involves bone. This detail changes your reimbursement level. Getting it wrong means leaving money on the table or inviting a post-payment audit.
RenewMed Tip: Medicare looks for this staging language, including how it connects your clinical findings to the billing code.
Payers look at the wound and the skin around it. Periwound findings confirm venous etiology and justify treatment.
Don't write "Periwound skin intact." Instead write, "Hemosiderin staining extending 4 cm from wound margins. Non-pitting edema to mid-calf. Lipodermatosclerosis consistent with CEAP C4b."
|
Finding |
Document This Way |
Why Payers Care |
|
Edema |
"Non-pitting edema extending to mid-calf, reducing with elevation" |
Confirms venous pathology; justifies compression billing |
|
Hemosiderin staining |
"Hemosiderin staining extending 4 cm from wound margins" |
Establishes chronicity; supports advanced therapy authorization |
|
Lipodermatosclerosis |
"Lipodermatosclerosis with subcutaneous fibrosis noted periwound" |
Documents CEAP C4b; strengthens case for advanced intervention |
|
Venous eczema |
"Venous eczema with erythema and scaling surrounding wound bed" |
Supports C4a classification and treatment necessity |
The same finding can trigger approval or denial depending on phrasing.
The pattern: payers want numbers, timeframes, and named criteria.
Each assessment finding narrows your treatment options and builds a reimbursement case.
Yes. ABI testing is billable under CPT 93922 (limited bilateral noninvasive physiologic study). Append modifier 59 when performed on the same day as wound care.
Connect the test to the clinical question: "ABI performed to assess arterial sufficiency prior to initiating compression therapy."
Reassess ABI every 8 to 12 weeks during active treatment or sooner if the wound isn't responding as expected. A declining ABI may signal progressing arterial disease that changes your compression approach.
Document each reassessment value with the date and any treatment plan changes it prompted. Auditers may question ongoing compression therapy if you haven't documented a recent ABI confirming it's still safe.
Document the refusal, the education you provided, and the alternative plan. Non-compliance with compression doesn't disqualify patients from advanced therapies. But payers expect documentation showing you addressed it.
Note specific barriers (pain, mobility issues, lifestyle factors) and what modified approaches you offered. Lower compression levels, different wrap systems, and patient education materials all count as alternatives worth documenting.
Every detail you capture (ABI values, CEAP staging, periwound findings) shapes treatment decisions and Medicare’s responses. A complete assessment protects your practice financially.
Through our White Glove Service, your dedicated RenewMed consultant handles product review, pre-authorization, and billing support.
Speak to a RenewMed Consultant
Better Patient Outcomes, Less Administrative Pain.
Disclaimer: This content is created for licensed healthcare professionals, offering educational insights into wound care. It is not intended as medical advice or to replace your own clinical judgment when treating patients. We're here to support you, but the final treatment decisions should always be based on your professional evaluation of each unique patient's needs.